All treatments
Treatment
Placebo for Rimegepant 75 mg clinical trials
2 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic use (Phase IV)
C4951004 - BHV3000-406: A Phase 4, Randomized, Double-blind Placebo Controlled, Efficacy and Tolerability Trial of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan Use
This study looks at how well a medication called VYDURA (rimegepant) works for adults who get migraine headaches but can't use common migraine drugs called triptans. It also checks if the medication is safe to use.
For: Migraine attacks with or without auraFinland · Germany · Sweden - Ongoing, recruitingTherapeutic use (Phase IV)
C4951012 - BHV3000-407: A Phase 4, Randomized, Double-blind, Placebo controlled Study to Evaluate the Efficacy and Tolerability of Rimegepant for the Prevention of Migraine in Adults with a History of Inadequate Response to Oral Preventive Medications
This study is testing a new medicine, Rimegepant (also known as VYDURA), to see if it can help prevent migraine headaches. It's for adults who've tried other migraine prevention medicines without much success. Researchers want to know if it reduces how often migraines happen.
For: migraine headaches with or without auraBelgium · Germany · Sweden